Microbiome focus
Research and product work relating to the intestinal microbiome and probiotic medicinal products.
Research & microbiome
Since 1970, Ardeypharm has developed probiotic and herbal medicinal products with a particular connection to intestinal health and the microbiome.
Ardeypharm was founded in 1970 and develops probiotic and herbal medicinal products with a particular connection to intestinal health.
Ardeypharm has worked on microbiological therapies since 1970. Scientific work and collaborations accompany its product and research activities relating to the intestinal microbiome.
Research and product work relating to the intestinal microbiome and probiotic medicinal products.
Herbal medicinal products complement the pharmaceutical portfolio.
Focus areas
Four fields of expertise define the company’s work on sustainable medicinal products.
Product and research work with selected microbiological cultures.
Research and a medicinal product portfolio relating to intestinal flora and the microbiome.
Medicinal products based on herbal active ingredients complement the portfolio.
Scientific work and collaborations accompany development.
Medicinal products
A long-established product in Ardeypharm's portfolio, Mutaflor combines the company's microbiome expertise with E. coli strain Nissle 1917.
The liquid dosage form from the Mutaflor portfolio with E. coli strain Nissle 1917.
Containing the medicinal yeast Saccharomyces boulardii, Yomogi is part of Ardeypharm's probiotic medicinal product portfolio.
Juniorlax complements Ardeypharm's paediatric medicinal product portfolio.
Find information on Mutaflor, Yomogi and Juniorlax directly on their respective product websites.